The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Segal Lloyd Mitchell since 2012.
This trader's CIK number is 1477123.
At the time of last reporting, Segal Lloyd Mitchell was the PRESIDENT AND CEO of Repare Therapeutics Inc.. (stock ticker symbol RPTX).
Also see all insider trading activities at Repare Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | RPTX | 0 | $0 | 21,179 | $24,144 | 0 | $0 |
| 2024 | RPTX | 0 | $0 | 13,091 | $61,034 | 0 | $0 |
| 2021 | RPTX | 0 | $0 | 14,882 | $521,269 | 0 | $0 |
| 2020 | RPTX | 5,000 | $100,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | VRX | 3,330 | $280,415 | 0 | $0 | 0 | $0 |
| 2012 | VRX | 1,225 | $66,609 | 0 | $0 | 0 | $0 |
1. Repare Therapeutics Inc. (RPTX)
2. Bausch Health Companies Inc. (VRX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-12 | RPTX | Sale | 21,179 | 1.14 | 24,144 |
| 2024-03-28 | RPTX | Sale | 2,650 | 4.62 | 12,243 |
| 2024-04-01 | RPTX | Sale | 2,491 | 4.63 | 11,533 |
| 2024-03-25 | RPTX | Sale | 2,650 | 4.79 | 12,693 |
| 2024-03-26 | RPTX | Sale | 2,650 | 4.64 | 12,296 |
| 2024-03-27 | RPTX | Sale | 2,650 | 4.63 | 12,269 |
| 2021-05-20 | RPTX | Sale | 3,770 | 35.03 | 132,066 |
| 2021-05-18 | RPTX | Sale | 1,800 | 35.00 | 63,000 |
| 2021-05-19 | RPTX | Sale | 3,800 | 35.06 | 133,228 |
| 2021-04-15 | RPTX | Sale | 5,512 | 35.01 | 192,975 |
| 2020-06-23 | RPTX | Buy | 5,000 | 20.00 | 100,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-06-14 | VRX | Buy | 140 | 85.45 | 11,963 |
| 2013-06-11 | VRX | Buy | 690 | 86.53 | 59,702 |
| 2013-06-12 | VRX | Buy | 2,500 | 83.50 | 208,750 |
| 2012-11-09 | VRX | Buy | 240 | 54.28 | 13,027 |
| 2012-11-09 | VRX | Buy | 240 | 54.28 | 13,027 |
| 2012-11-06 | VRX | Buy | 745 | 54.44 | 40,555 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Segal Lloyd Mitchell (PRESIDENT AND CEO of Repare Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.